Stock BNGO BIONANO GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.968 USD -0.42% Intraday chart for Bionano Genomics, Inc. -9.53% -48.78%
May. 28 Bionano Genomics Raises $18 Million From Private Debentures Placement MT
May. 24 Bionano Genomics, Inc. announced that it has received $18 million in funding CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow
AQ
Bionano Genomics Raises $18 Million From Private Debentures Placement
MT
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
AQ
Bionano Genomics, Inc. announced that it has received $18 million in funding
CI
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy
AQ
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
AQ
Bionano Genomics, Inc. Announces Significant Upgrades to its Suite of Computational Tools for Comprehensive Cancer Analysis
CI
Transcript : Bionano Genomics, Inc., Q1 2024 Earnings Call, May 08, 2024
Bionano Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
AQ
Bionano Genomics, Inc. Provides Revenue Guidance for the Second Quarter of 2024 and Reiterated Revenue Guidance for the Year 2024
CI
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
AQ
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
AQ
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
AQ
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
AQ
Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health
MT
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
AQ
Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence
CI
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
AQ
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. News Bionano Genomics, Inc.